These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11990723)

  • 1. Baclofen prevents morphine withdrawal irrespective of seasonal variation.
    Kemmling AK; Rubio MC; Balerio GN
    Behav Pharmacol; 2002 Feb; 13(1):87-92. PubMed ID: 11990723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baclofen reestablishes micro-opioid receptor levels modified by morphine withdrawal syndrome in either sex.
    Diaz SL; Kemmling AK; Bonavita CD; Rubio MC; Balerio GN
    Synapse; 2004 Oct; 54(1):24-9. PubMed ID: 15300881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of mu-opioid receptors in prepubertal male and female mice.
    Diaz SL; Barros VG; Antonelli MC; Rubio MC; Balerio GN
    Synapse; 2006 Aug; 60(2):132-40. PubMed ID: 16715492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of sex-related differences in the prevention by baclofen of the morphine withdrawal syndrome in mice.
    Diaz SL; Kemmling AK; Rubio MC; Balerio GN
    Behav Pharmacol; 2001 Feb; 12(1):75-9. PubMed ID: 11270515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baclofen reestablishes striatal and cortical dopamine concentrations during naloxone-precipitated withdrawal.
    Diaz SL; Kemmling AK; Balerio GN
    Neurochem Int; 2003 Mar; 42(4):293-8. PubMed ID: 12470702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baclofen prevents the elevated plus maze behavior and BDNF expression during naloxone precipitated morphine withdrawal in male and female mice.
    Pedrón VT; Varani AP; Balerio GN
    Synapse; 2016 May; 70(5):187-97. PubMed ID: 26789010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baclofen did not modify sexually dimorphic c-Fos expression during morphine withdrawal syndrome.
    Pedrón VT; Taravini IR; Induni AS; Balerio GN
    Synapse; 2013 Mar; 67(3):118-26. PubMed ID: 23152154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic aspects of naloxone-precipitated morphine withdrawal in male and female prepubertal mice.
    Diaz SL; Hermida MP; Joannas LD; Olivera M; Ridolfi A; Villaamil EC; Balerio GN
    Biopharm Drug Dispos; 2007 Sep; 28(6):283-9. PubMed ID: 17570125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine withdrawal syndrome: involvement of the dopaminergic system in prepubertal male and female mice.
    Diaz SL; Kemmling AK; Rubio MC; Balerio GN
    Pharmacol Biochem Behav; 2005 Dec; 82(4):601-7. PubMed ID: 16325246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal.
    Varani AP; Moutinho LM; Calvo M; Balerio GN
    Drug Alcohol Depend; 2011 Dec; 119(1-2):e5-12. PubMed ID: 21733642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of morphine withdrawal signs by a GABAB receptor agonist in the locus coeruleus of rats.
    Riahi E; Mirzaii-Dizgah I; Karimian SM; Sadeghipour HR; Dehpour AR
    Behav Brain Res; 2009 Jan; 196(1):11-4. PubMed ID: 18634832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.
    Madhavan A; He L; Stuber GD; Bonci A; Whistler JL
    J Neurosci; 2010 Mar; 30(9):3276-86. PubMed ID: 20203187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in anterior pituitary hormone secretion and hypothalamic catecholamine metabolism during morphine withdrawal in the female rat.
    Gabriel SM; Simpkins JW; Millard WJ
    Brain Res; 1985 Oct; 346(1):15-21. PubMed ID: 4052762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J; Schulteis G
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA
    Pedrón VT; Varani AP; Bettler B; Balerio GN
    Pharmacol Biochem Behav; 2019 May; 180():11-21. PubMed ID: 30851293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Injection of Gamma-Aminobutyric Acid Agonists into the Nucleus Accumbens on Naloxone-Induced Morphine Withdrawal.
    Topkara B; Yananli HR; Sakallı E; Demirkapu MJ
    Pharmacology; 2017; 100(3-4):131-138. PubMed ID: 28637045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of noradrenergic functions in the modification of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes.
    Kamei J; Ohsawa M
    Life Sci; 1997; 60(15):PL223-8. PubMed ID: 9096248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the expression of naloxone-precipitated withdrawal signs in morphine-dependent mice by diabetes: possible involvement of protein kinase C.
    Ohsawa M; Kamei J
    Jpn J Pharmacol; 1999 Mar; 79(3):303-11. PubMed ID: 10230858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABAB receptors are involved in the control of acute opiate withdrawal in isolated tissue.
    Capasso A
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Feb; 23(2):289-99. PubMed ID: 10368870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.